Merger Notification - Announcement according to § 10 Cartel Act
Edwards Lifesciences Corporation; JenaValve Technology, Inc
BWB/Z-6717
On 12.09.2024 the Austrian Federal Competition Authority was notified of the following merger:
Planned purchase process
Edwards Lifesciences Corporation (USA) intends to acquire, by means of a merger between JenaValve Technology, Inc. (USA) and a wholly-owned subsidiary of Edwards Lifesciences Corporation, all shares in, and sole control of, JenaValve Technology, Inc.
The transaction concerns medical devices for use in heart diseases (mechanical heart valves).
Industry sector: C - Verarbeitendes Gewerbe/Herstellung von Waren
Deadline for bringing in an application pursuant to § 11(1) Cartel Act will end on 24.10.2024.
Entrepreneurs whose legal or economic interests are affected by the merger can bring in a written statement at the Federal Competition Authority or the Federal Cartel Prosecutor within 14 days from publication date.
Note: The intervening party has no right to a certain treatment of the statement and will not gain a party position.
On October the 8th 2024 the applicant requested the extension of the deadline for the submission of an application for examination by two weeks, pursuant to § 11 (1a) Cartel Act. The deadline for the submission of an application for examinations by the administrative authorities is extended by two weeks, thus ending on October the 24th 2024.